CRPC — Critical Reagent Processing Share Price
Last trade - 00:00- CA$0.53m
- -CA$1.19m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.27 | ||
| Price to Tang. Book | 0.27 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -24.07% | ||
| Return on Equity | -21.49% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Critical Reagent Processing Corp is a Canada-based company, which is engaged in the fast-tracking exploration of sodium carbonate deposits. The Company’s principal activity is the acquisition and exploration of mineral properties. The Company owns a 100% interest in the Mina Laguna Santa Maria Project, located in Salta Province, Argentina. The project is composed of two mining concessions, which total 500 hectares. The two concessions are licensed for the production of sodium carbonate, commonly referred to as soda ash, which is a key reagent in the production of lithium carbonate. The Company conducts its operations in Canada, Argentina, and Australia with one business segment being the exploration of resource properties. It is evaluating the project for the potential to provide sodium carbonate to nearby lithium carbonate production.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 14th, 2016
- Public Since
- October 13th, 2017
- Sector
- Metals & Mining
- Industry
- Basic Materials
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 7,032,298
- Address
- 1681 Chestnut Street, Suite 400, VANCOUVER, V6J 4M6
- Web
- https://www.crpc-corp.com/
- Phone
- +1 6049083095
- Auditors
- DALE MATHESON CARR-HILTON LABONTE LLP
Upcoming Events for CRPC
Similar to CRPC
37 Capital
Canadian Securities Exchange
55 North Mining
Canadian Securities Exchange
Abitibi Metals
Canadian Securities Exchange
Adelphi Metals
Canadian Securities Exchange
Adonis Minerals
Canadian Securities Exchange
FAQ
As of Today at 20:06 UTC, shares in Critical Reagent Processing are trading at CA$0.08. This share price information is delayed by 15 minutes.
Shares in Critical Reagent Processing last closed at CA$0.08 and the price had moved by -70% over the past 365 days. In terms of relative price strength the Critical Reagent Processing share price has underperformed the Toronto Stock Exchange 300 Composite Index by -73.33% over the past year.
There is no consensus recommendation for this security.
Find out moreCritical Reagent Processing does not currently pay a dividend.
Critical Reagent Processing does not currently pay a dividend.
Critical Reagent Processing does not currently pay a dividend.
To buy shares in Critical Reagent Processing you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.08, shares in Critical Reagent Processing had a market capitalisation of CA$0.53m.
Here are the trading details for Critical Reagent Processing:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: CRPC
Based on an overall assessment of its quality, value and momentum Critical Reagent Processing is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Critical Reagent Processing. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -50.29%.
As of the last closing price of CA$0.08, shares in Critical Reagent Processing were trading -60.29% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Critical Reagent Processing PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Critical Reagent Processing's management team is headed by:
- Adrian Hobkirk - PRE
- Teresa Cherry - CFO
- Christopher Cherry - IND
- William Feyerabend - IND